• No results found

University of Groningen Chronic abdominal pain, fatigue and inflammatory bowel disease in children Van de Vijver, Els

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Chronic abdominal pain, fatigue and inflammatory bowel disease in children Van de Vijver, Els"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Chronic abdominal pain, fatigue and inflammatory bowel disease in children Van de Vijver, Els

DOI:

10.33612/diss.147541085

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2020

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Van de Vijver, E. (2020). Chronic abdominal pain, fatigue and inflammatory bowel disease in children. University of Groningen. https://doi.org/10.33612/diss.147541085

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

STELLINGEN

1. A fecal calprotectin result below 50 µg/g reduces the likelihood of IBD in children to such an extent that doctors should refrain from endoscopy. 2. Compared to fecal calprotectin, a normal calgranulin C result is equally

reliable to rule out intestinal inflammation.

3. A raised fecal calprotectin is insufficient proof of IBD.

4. A combination of gastrointestinal symptoms, CRP, haemoglobin and calprotectin is highly accurate to consider the diagnosis IBD in children. 5. Testing of disease activity, anxiety and depression, and functional

capacity are essential components of a personalised management of fatigue in paediatric IBD.

6. Fatigued and non-fatigued IBD patients are more similar than different in haemoglobin and fecal calprotectin levels.

7. Children with IBD and fatigue have a compromised quality of life.

8. Minds are like parachutes: they only function when open - Thomas Dewar- cfr Professor J Ramet.

9. The important thing is not to stop questioning. Curiosity has its own reason for existing – Albert Einstein.

10. Als je tijd geeft aan moeilijk, dan wordt moeilijk gemakkelijk. - Ish Ait Hamou.

Referenties

GERELATEERDE DOCUMENTEN

GWAS typically ascertain at least 300.000 common single nucleotide polymorphisms (SNPs) throughout the genome, and for each of these variants the association is tested

The genetic risk loci identified for IBD so far have shed new light on the biological pathways underlying the disease. The translation of all of this knowledge

Results for the allelic association analysis for replication phases 1 and 2 are depicted in Tables 2 and 3. In the first replication phase, 10 SNPs were tested in a Dutch cohort of

We undertook a study in a Dutch cohort of UC patients and tested these three new associated loci (HNF4-α, CDH1, LAMB1) in 821 UC patients and 1260 controls..

4.. b) All variants called by two alignment strategies were included and filtered using a Forward/Reverse balance between 20-80%. c) Variants previously tested in a large IBD

Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. NHLBI

Percentages of correct answers over all Montreal items give a good reflection of the inter-observer agreement (> 80%), except for disease severity (48%-74%).. IBD-nurses

We have identified a variant in WWOX and in lncRNA RP11-679B19.1, as a disease- modifying genetic variant associated with recurrent fibrostenotic CD and